Havemeyer Place’s Halozyme HALO Stock Holding History

Havemeyer Place’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	15,876 +2,688	+20%	+$183K	0.12%	270
2026 Q1	$852K	Buy	13,188 +612	+5%	+$43.1K	0.1%	335
2025 Q4	$846K	Buy	+12,576	New	+$846K	0.17%	222

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Havemeyer Place's HALO Position: Q2 2026 in Review

Havemeyer Place increased its Halozyme (HALO) stake by 20% in Q2 2026, buying an estimated $183K and bringing the position to 15,876 shares worth $1.24M. The position accounts for 0.12% of the portfolio, ranked #270.

Havemeyer Place first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Havemeyer Place held 15,876 shares of Halozyme worth $1.24M as of Q2 2026.
Havemeyer Place bought 2,688 Halozyme shares in Q2 2026, an estimated $183K.
Halozyme made up 0.12% of Havemeyer Place's portfolio in Q2 2026, its #270 holding.
Havemeyer Place first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.